Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021

This report summarises current knowledge and presents key messages from the International CTEPH Conference, Bad Nauheim, Germany, 2021. Sessions were dedicated to 1) disease definition; 2) pathophysiology, including the impact of the hypertrophied bronchial circulation, right ventricle (dys)function, genetics and inflammation; 3) diagnosis, early after acute pulmonary embolism, using computed tomography and perfusion techniques, and supporting the selection of appropriate therapies; 4) surgical treatment, pulmonary endarterectomy for proximal and distal disease, and peri-operative management; 5) percutaneous approach or balloon pulmonary angioplasty, techniques and complications; and 6) medical treatment, including anticoagulation and pulmonary hypertension drugs, and in combination with interventional treatments. Chronic thromboembolic pulmonary disease without pulmonary hypertension is also discussed in terms of its diagnostic and therapeutic aspects.

Source: European Respiratory Review - February 7, 2023 Category: Respiratory Medicine Authors: Simonneau, G., Fadel, E., Vonk Noordegraaf, A., Toshner, M., Lang, I. M., Klok, F. A., McInnis, M. C., Screaton, N., Madani, M. M., Martinez, G., Salaunkey, K., Jenkins, D. P., Matsubara, H., Brenot, P., Hoeper, M. M., Ghofrani, H. A., Jaïs, X., W Tags: Interstitial and orphan lung disease The world of rare lung diseases Source Type: research